Dr. Alessandra Yu Chen, MD

Dr. Chen practices at Primary & Specialty Care - Mercy Medical Group - Citrus Heights, CA in Citrus Heights, California.

Dr. Chen's NPI, 1902367378, was assigned on March 28, 2019. Dr. Chen graduated from David Geffen School of Medicine at UCLA in 2019. Dr. Chen holds California license A179190.

Dr. Chen's primary practice is Primary & Specialty Care - Mercy Medical Group - Citrus Heights, CA, at 7115 Greenback Lane Floor 1,2,3, Citrus Heights, CA 95621. The practice phone is (916) 379-2861.

Dr. Chen's primary practice is Primary & Specialty Care - Mercy Medical Group - Citrus Heights, CA in Citrus Heights, California. Dr. Chen is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Chen to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Chen's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Chen is board certified in dermatology by the American Board of Dermatology. Dr. Chen is licensed in California.

CMS data shows 265 Medicare services from Dr. Chen across 8 procedure codes in 2024, for 172 Medicare patients. Medicare paid $22,707 for them. Every service was in an office.

CMS counts 172 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 84 patients. 72% of them have high cholesterol, and 64% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 61, with 58% women.

In 2024, Dr. Chen wrote 383 Medicare Part D claims for 283 patients. 99% of them were for generic drugs. CMS names the drug for 312 of them, across 7 drugs with 11 or more claims each, at $2,356 in total drug cost. In 2023, CMS named 199 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth. CMS counts 185 procedures of melanoma (skin cancer) excision by Dr. Chen, more than 97% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Chen, published from 2020 to 2024. 2024 was the busiest year, with 2. Dr. Chen has published most often in JAAD Case Rep. Dr. Chen's most frequent co-authors are Naomi Felisa Briones, MD, Brian Robert Hinds, MD and Helen Park.

CMS Open Payments shows 31 general payments to Dr. Chen from 12 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 86% of the total. Sanofi and Genzyme US Companies paid the most, $558.

Dr. Chen graduated from David Geffen School of Medicine at UCLA in 2019.

Dr. Chen is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.